In The Lancet, MSF Access Campaign challenges the status quo of patents and other intellectual property blocking access to COVID-19 medical tools.

MSF joined other CSOs in this open letter to the WTO Director General on the TRIPS Waiver, calling for equitable access to COVID-19 medical tools

Letter from MSF and civil society organisations to diagnostics corporation Cepheid calling for reinstating launch of TB testing system GeneXpert Omni.

MSF and civil society organizations (CSOs) in South Africa sent the following letter to the embassies of countries blocking or delaying the TRIPS Waiver on COVID-19 medical tools.

TB LAM tests for TB diagnosis must be adopted by countries with high TB burden, and Abbott must make its current TB LAM test more accessible

MSF sent another open letter urging AbbVie to make glecaprevir/pibrentasvir (G/P) accessible for people with hepatitis C in LMICs

Open letter from CSOs to the European Commission to stop blocking the WTO TRIPS Waiver on intellectual property of COVID-19 medical tools

Open letters to US President Biden and to US Trade Representative to swiftly implement the WTO TRIPS Waiver on IP of all COVID-19 medical tools

Open letter sent to Gilead and Viatris calling for affordable access to liposomal amphotericin B (L-AmB) to treat mucormycosis (black fungus)

Open letter sent to WHO and ACT-A calling for access to liposomal amphotericin B (L-AmB) to treat mucormycosis (black fungus) and other diseases

MSF sent a letter to the new United States Trade Representative requesting that the Special 301 Report, starting from the 2021 edition and onward, does not penalize countries for using public health safeguards in their national laws or ...

To Help End the Pandemic as Quickly as Possible and Restore U.S. International Cooperation, Please End Trump’s Blockade of the COVID-19 Emergency Waiver of WTO Rules So More Vaccines and Treatment Can Be Produced

Civil society organizations signed on to this letter are encouraged that you would like to contribute to addressing the global challenges of inadequate supply and inequitable access to COVID-19 medical products, especially vaccines.

Civil society groups and MSF have sent another letter, urging donors, countries and other international health actors to reiterate its demands that Cepheid stop overcharging and undersupplying LMICs.

An open letter by Christos Christou, International President of Médecins Sans Frontières (MSF), asking governments blocking or delaying the decision on a landmark request at the World Trade Organization (WTO) to stop stalling the ...

Since the start of the COVID-19 pandemic, Cepheid has overcharged and undersupplied COVID-19 tests for low- and middle-income countries (LMICs). Ahead of the next round of price negotiations between the COVID-19 Diagnostics Consortium ...

Since October 2020, MSF has reached out to governments calling for support of the landmark proposal for a waiver of certain intellectual property provisions under the TRIPS agreement during the COVID-19 pandemic. We have received ...

On 19 November 2020, more than 100 civil society organisations, including MSF Access Campaign, sent an open letter to European Parliament calling for support for India, South Africa, Eswatini and Kenya´s landmark proposal for a ...